Regulatory
-
Artificial Intelligence's Potential In Pharma Manufacturing
6/13/2025
Explore how pharma companies can leverage Stevanato Group’s AI technologies while navigating FDA’s evolving, risk-based regulatory approach to disruptive innovations in this webinar.
-
Navigating GxP Compliance Challenges
10/30/2024
Learn how to select and manage trusted software suppliers to streamline your digital transformation, mitigate risks, and ensure regulatory adherence. Watch to discover best practices and real-world examples.
-
Streamline Global Regulatory Submissions
5/21/2026
Discover a more streamlined approach with one accountable partner supporting regulatory submissions globally.
-
Annex 1 FAQs: How Are We Responding To Foster Trust With Customers?
5/11/2026
When regulations evolve, your suppliers’ ability to adapt shapes your ability to deliver. Learn how stronger manufacturing, quality, and personnel standards combined with radical transparency make compliance an advantage.
-
The Container Closure Integrity Requirements In The Revised EU Annex 1
Learn about the advantages and disadvantages of CCI testing methods, how the revised EU Annex 1 may impact your strategy for ensuring CCI of sterile pharmaceutical products, and more.
-
Seal-Sensor Technology For In-Line Pouch Seal Inspection
11/16/2021
PTI is integrating the latest technologies for inspecting pouch seals utilizing a method that inspects and analyzes pouch seals non-destructively. Seal-Scan and Seal-Sensor utilize Airborne Ultrasonic Technology (ABUS) that inspects and analyzes pouch seals non-destructively.
-
Annex 1 FAQs: Responding To The 2022 Revision
5/11/2026
Viewing the Annex 1 revision as a natural extension of current habits, rather than a burden, allowed for a seamless transition. Since contamination control was already standard, the update simply validated existing excellence.
-
Your Contract Manufacturer Partner
12/14/2020
Discover an integrated solution for pharmaceutical companies that offers a broad range of manufacturing services and capabilities to produce high-quality devices.
-
Importance Of Architectural Layout To Prevent Contamination
8/21/2025
In this segment from the Pharmaceutical Online Live event, “Contamination Control Strategies For Drug Manufacturers,” panelists discuss the importance of unidirectional flow for preventing contamination, as well as specific architectural requirements related to the European Union's Annex 1 regulations. Poor or aging facility design is not an acceptable excuse for noncompliance.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
12/5/2023
Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.